What year was noted as particularly significant for new biotech drug approvals in the US?
Understand the Problem
The question is asking about a specific year that is considered important for the approval of new biotech drugs in the United States. It requires knowledge about drug approval timelines and significant events in biotechnology history.
Answer
2023
The year 2023 was noted as particularly significant for new biotech drug approvals in the US.
Answer for screen readers
The year 2023 was noted as particularly significant for new biotech drug approvals in the US.
More Information
The year 2023 saw a particularly high number of biotech drug approvals. It marked significant advancements in the field, including the approval of novel gene therapies and the first CRISPR–Cas9-edited therapy.
Sources
AI-generated content may contain errors. Please verify critical information
